Tsung-I Hsu

17PUBLICATIONS
23CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene and molecular therapyCheminformatics and quantitative structure-activity relationshipsNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 17, 2025
A Dual CYP17A1/HDAC6 Inhibitor for Targeted Prostate Cancer Therapy.

Hoang Yen Tran, Chien-Liang Lin, Hong-Yi Lin

|Jul 14, 2025
Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood-Brain Barrier Crossing Celecoxib Derivative.

Chih-Jie Shen, Hsien-Chung Chen, Chien-Liang Lin

|Jan 21, 2025
Repurposing Linezolid in Conjunction with Histone Deacetylase Inhibitor Access in the Realm of Glioblastoma Therapies.

I-Chung Chen, Hong-Yi Lin, Zheng-Yang Liu

|Aug 05, 2024
Progesterone boosts abiraterone-driven target and NK cell therapies against glioblastoma.

Hsien-Chung Chen, Hong-Yi Lin, Yung-Hsiao Chiang

|Jan 29, 2024
First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo.

Sachin Sharma, Shao-An Wang, Wen-Bin Yang

Pageof 3